Prevent Cancer Dialogue: Prevention, Screening, Action

ÉVÉNEMENTS

Dialogue sur la prévention du cancer

Discover and discuss the latest advances in research, policy and program best practices in cancer prevention and early detection.

Le Dialogue sur la prévention du cancer brings together a diverse group of partners to discuss the latest advances in research, policy, practice and programs in cancer prevention and early detection. Experts in the field give timely and enlightening presentations on trending topics with opportunities for discussion and peer-to-peer conversations among participants. Participants take Dialogue learnings back to their communities and workplaces to enhance or expand their work.

2025 Prevent Cancer Dialogue Virtual Series

This series of three 90-minute webinars will feature presentations from experts in the field and moderated discussions with the audience. Continuing education credit will be offered. Registration is free of charge!

  • April 2, 2025: Updates on young-onset cancers: What to know and public health implications
  • June 4, 2025: Diversifying clinical trial participation: Pathways from screenings to trials
  • October 8, 2025: Minimal residue disease (MRD): Exploring the impact of cancer early detection and personalized care

EN SAVOIR PLUS ET INSCRIRE

Stay Connected

Receive updates on our Dialogue sur la prévention du cancer series and other learning opportunities.

Sign Up

Special thank you to the 2025 Dialogue supporters!

If your organization  would like to support the 2025 Prevent Cancer Dialogue, or for more information on how you can become a corporate partner of the Prevent Cancer Foundation, please contact Jennifer Niyangoda at 703-837-3684 or Jennifer.Niyangoda@preventcancer.org.

 

Rencontrez le Groupe consultatif sur le dialogue

Fait marquant du Dialogue 2023

Découvrez un moment fort du Dialogue 2023 avec le Dr Robert Winn, qui discute de l'importance d'une approche communautaire pour réduire les disparités en matière de santé dans le dépistage du cancer.